Finance

Lists
Why is RXST down 3.04%?
Dive Deeper
RXST:NASDAQ
Rxsight Inc
$4.47
-3.04%
(-0.14) 1D
$4.47
0.00% (0.00)
After hours
Closed: Nov 20, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RXST...
Open
$4.56
High
$4.75
Low
$4.45
Mkt. cap
187.42M
Avg. vol.
871.12K
Volume
539.31K
52-wk high
$13.22
52-wk low
$4.11
EPS
-$1.29
Beta
1.21
Shares outstanding
41.93M
No. of employees
461
Open
$4.56
High
$4.75
Low
$4.45
Mkt. cap
187.42M
Avg. vol.
871.12K
Volume
539.31K
52-wk high
$13.22
52-wk low
$4.11
EPS
-$1.29
Beta
1.21
Shares outstanding
41.93M
No. of employees
461
News stories
From web sources and news partners
About Rxsight Inc
CEO-
Employees461
Founded1997
HeadquartersAliso Viejo, California, United States
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 6 analysts giving stock ratings to RXST in the past 3 months
Hold
Buy
0
Hold
5
Sell
1
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for RXST in the last 3 months.
Highest
Current $4.47
$8.00 (+78.97%)
Average
$6.19 (+38.48%)
Lowest
$5.00 (+11.86%)
Analyst
Recommendation
Action
Price target
Projected
Date
Stephanie Elghazi
Bank of America Securities
Sell
Maintained
-
-
11/04/2026
Ryan Zimmerman
BTIG
Hold
Maintained
-
-
11/03/2026
Adam Maeder
Piper Sandler
Hold
Maintained
$8.00
+79%
11/04/2026
Thomas Stephan
Stifel Nicolaus
Hold
Maintained
$5.00
+11.9%
11/04/2026
Larry Biegelsen
Wells Fargo
Hold
Reiterated
$6.00
+34.2%
11/04/2026
Young Li
Jefferies
Hold
Maintained
$5.75
+28.6%
09/22/2026
Craig Bijou
Bank of America Securities
Sell
Reiterated
$5.50
+23%
09/22/2026
Steven Lichtman
William Blair
Hold
Maintained
-
-
08/07/2026
Robbie Marcus
J.P. Morgan
Sell
Maintained
$6.00
+34.2%
08/06/2026
Travis Steed
Bank of America Securities
Sell
Reiterated
$6.50
+45.4%
08/05/2026
Patrick Wood
UBS
Hold
Maintained
$6.30
+40.9%
08/06/2026
David Saxon
Needham
Buy
Maintained
$11.00
+146.1%
08/06/2026
Danielle Antalffy
UBS
Hold
Initiated
$5.50
+23%
07/28/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
$9.00
+101.3%
07/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
32.61M
30.89M
33.74M
24.59M
Cost of goods sold
7.34M
7.40M
7.86M
6.49M
Cost of revenue
7.34M
7.40M
7.86M
6.49M
Research and development expenses
8.90M
9.47M
9.24M
9.21M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.70M
31.86M
30.42M
27.40M
Operating expense
36.60M
41.33M
39.66M
36.62M
Total operating expenses
43.94M
48.72M
47.51M
43.10M
Operating income
-11.34M
-17.83M
-13.77M
-18.52M
Other non operating income
-
-
-
-
EBT including unusual items
-9.15M
-15.88M
-12.01M
-16.20M
EBT excluding unusual items
-9.15M
-15.88M
-12.01M
-16.20M
Income tax expense
5.00K
6.00K
88.00K
28.00K
Effective tax rate
-0.05%
-0.04%
-0.73%
-0.17%
Other operating expenses
-
-
-
-
Net income
-9.15M
-15.88M
-12.10M
-16.22M
Net profit margin
-28.07%
-51.42%
-35.85%
-65.99%
Earnings per share
-0.03
-0.19
-0.11
-0.21
Interest and investment income
2.20M
1.95M
1.76M
2.32M
Interest expense
-5.00K
-3.00K
-3.00K
-3.00K
Net interest expenses
2.19M
1.95M
1.76M
2.32M
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.49M
-17.00M
-12.77M
-17.59M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps